DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors

2024-9-13

Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression

2024-9-12

Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study

2024-9-12

Specific features of ß-catenin-mutated hepatocellular carcinomas

2024-9-11

Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study

2024-9-11

Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer

2024-9-9

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial

2024-9-7

Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors

2024-9-4

Comorbidity in patients with cancer treated at The Christie

2024-9-4

The scienthetic method: from Aristotle to AI and the future of medicine

2024-9-3

Efficacy and safety evaluation of androgen deprivation therapy-based combinations for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis

2024-9-2

Peritumoral tissue (PTT): increasing need for naming convention

2024-9-2

Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression

2024-8-31

Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer

2024-8-31

Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy?

2024-8-31

Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC)

2024-8-30

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

2024-8-30

Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study

2024-8-30

Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning

2024-8-28

Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer

2024-8-28

Pursuit of the optimal therapeutic approach and intensity for children with bilateral Wilms tumour

2024-8-27

What kind of tumour rupture requires adjuvant therapy?

2024-8-27

Intention to have blood-based multi-cancer early detection (MCED) screening: a cross-sectional population-based survey in England

2024-8-27

Correction: Development and validation of a circulating microRNA panel for the early detection of breast cancer

2024-8-27

Prognostic value of post-operative iron biomarkers in colorectal cancer: population-based patient cohort

2024-8-27

Correction to: Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

2024-8-26

IMPRESS: Improved methylation profiling using restriction enzymes and smMIP sequencing, combined with a new biomarker panel, creating a multi-cancer detection assay

2024-8-24

The effect of comorbidities on diagnostic interval for lung cancer in England: a cohort study using electronic health record data

2024-8-23

DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt/β-catenin signaling axis in liver cancer

2024-8-22

Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma

2024-8-22

Pre-treatment magnetic resonance imaging in anal cancer: large-scale evaluation of mrT, mrN and novel staging parameters

2024-8-21

Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial

2024-8-20

Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

2024-8-19

Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities

2024-8-14

Cost-effectiveness of point of care smoking cessation interventions in oncology clinics

2024-8-14

Potential role of the CD39-CD73 ATP-adenosine pathway in platelet mediated dissemination of circulating tumour cells

2024-8-11

Sugar and sugar-sweetened beverages in relation to premature aging in adult survivors of childhood cancer

2024-8-8

CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer

2024-8-8

Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

2024-8-8

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade

2024-8-3

Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis

2024-8-2

Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors

2024-8-2

Comment on: “A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures”

2024-8-1

Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers

2024-7-31

Correction: Epithelial−mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer

2024-7-30

Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG)

2024-7-30

Prevalence of opioid misuse in patients with cancer: a systematic review and meta-analysis

2024-7-26

COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer

2024-7-25

Correction: Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland – a scoping review

2024-7-25

Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis

2024-7-19